designed a randomized controlled trail in 80 breast cancer patients, they reported that the total intravenous anesthesia can inhibit the release of vascular endothelial growth factor C (VEGF-C) in breast surgery, yet with no significant benefice in the short-term recurrence rate of breast cancer. The gene discussed is VEGFC; the disease is breast carcinoma.